PESHAWAR: The dangerous third wave of coronavirus in Khyber Pakhtunkhwa is continuing as on Friday the province reported 1,248 more coronavirus cases and 34 deaths.

Pakistan reported 105 more fatalities in the last 24 hours, taking the national death toll to 15,229.

According to the latest data of National Command and Operations Centre (NCOC), 5,312 new cases were reported in the country with the total tally now recorded at 710,829.

The positivity rate of coronavirus in Pakistan is 9.6 percent at present, while the number of active cases stands at 69,811. Pakistan reported 2,390 coronavirus recoveries during the last 24 hours. The total has risen to 625,789 and the recovery rate is 88.0 per cent.

In KP, the number of coronavirus patients has been recorded at 96,128 with 2,553 deaths while in Azad Kashmir, 14,069 cases have so far been reported with 391 deaths.

The total number of coronavirus patients in Sindh has reached 267,970 while 4,521 people have died in the province so far since the pandemic hit the country last year. The total number of COVID patients in Punjab is 243,295 and 6,851 people have died due to the virus, while the total number of patients in Balochistan is 20,097 and the death toll is 19,295.

In Gilgit-Baltistan, 5,064 cases have been reported, while 103 people have lost their lives to the virus.

According to the NCOC data, the total number of coronavirus patients in Islamabad is 62,775 and 588 patients have died from the virus so far.

After alarming increase in corona cases during the third wave, the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac. This would be the fifth coronavirus vaccine and the third Chinese vaccine to be used in Pakistan.

Earlier, Pakistan had granted the EUA to China’s two-dose Sinopharm and single-dose Convidecia vaccine developed by the Cansino Biologicals Inc. UK’s AstraZeneca and Russian Sputnik V vaccines have also been approved by the DRAP.

The CoronaVac vaccine, despite its low efficacy rate was allowed by the health authorities to counter the third wave of the pandemic in Pakistan.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here